Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

In 2015, 960,000 people were newly-infected with HIV in Eastern and Southern Africa.

The products include those intended for dermatological purposes, for instance, ointments, washes and creams that were never tested or approved to be sold in retail stores.

This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.

A job offer means that the company wants you more than all the other candidates. This should be encouraging!

Summer is approaching, and that means more scrapes, burns, and rashes as more people head outdoors, but 9 products used to treat these conditions are being recalled.

Although you are aware that this is a reality for many people in this economy, you never thought that you would join the no-raise ranks.

In one form or another, we will fall short in our expectations.

This article highlights 5 published case reports that document unusual drug overdoses.

Museums are a great way to expand your knowledge and add culture to your life.

The other day I began watching television and a show was on that you may all be familiar with called “My Strange Addiction.

This article will describe the unusual discovery of 5 commonly prescribed medications, many of which occurred through serendipitous events.

Like other non-steroidal anti-inflammatory drugs (NSAIDs), ketorolac works on cyclooxygenase enzymes (COX) and inhibits prostaglandin synthesis.

Officials with the FDA noted this this public meeting is designed to bring new ideas to the table on how to combat drug addiction in the most effective way possible.

Tom Frank, PharmD, BCPS, Director or Research and Education at the University of Arkansas for Medical Sciences discusses the role of new digital technologies in the management of type 2 diabetes.

McKesson Specialty Health and the US Oncology Network have expanded their agreement with the National Comprehensive Cancer Network adding five additional disease states to Value Pathways powered by NCCN.

More than 1 million Americans suffer myocardial infarctions annually.

The journal Research and Social and Administrative Pharmacy has published a study about the pharmacist's role in vaccinating asplenic patients.

Scientific inquiry stands as the basis of so many advances in our society that it seems inconceivable to question the return on investment in science.

CVS Health, in partnership with Drug Store News and Mack Elevation, will hold an innovation summit that brings together leaders from major health care, technology and consumer brands including Facebook, Under Armour, Google and IBM, among others, for a discussion about emerging trends that are helping reshape the health care industry.

Adolescents and young adults with type 1 diabetes benefit from a structured transition program when changing from pediatric to adult diabetes care.

These data, from the integrated analysis of the CANVAS and CANVAS-R trials, demonstrated the CV safety of canagliflozin (P

According to information on the conference website, ThoughtSpot gives independent community pharmacies practical information in growing their business goals and revenue through education sessions, while also providing opportunities for exclusive deals on product purchases at the show.

Results of this trial were presented at the ADA Meeting in San Diego.

Over the years, a number of landmark clinical studies on smoking cessation pharmacotherapy have been published, shaping how we treat people today. Here are 5 of those that every pharmacist should know:

Taking advantage of all the value that nonpharmacy organizations have to offer.

Metformin may be an effective long-term strategy worthy of adding to an individual’s diabetes care plan to reduce the risk of heart disease in adults with type 1 diabetes.

The results of the ODYSSEY-Diabetes trials focused on alirocumab, an approved monoclonal antibody that prevents PCSK-9 protein from impairing the liver’s receptors, and that antibody's effect on type 2 diabetes (T2D).